Modern drug discovery and development is driven by automation, high-throughput screening and a shift toward more relevant 3D cell culture models. Our bioprinting solutions allow for rapid generation of 3D cell cultures, tissue and disease models. In addition, we offer the largest selection of pure, high-quality bioinks and protocols. Our liquid-handling solutions enable fully automated compound screening, highly multiplexed assembly of chemical reactions and more flexibility in assay development. For automated monitoring of cell-based assays, we developed an innovative live-cell imaging system.